FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2554368131> ?p ?o ?g. }

• W2554368131 endingPage "e4962" @default.
• W2554368131 startingPage "e4962" @default.
• W2554368131 abstract "Mirabegron, which was the first β3-adrenoceptor agonist introduced for use in clinical practice, has been extensively evaluated in overactive bladder (OAB) patients in several phase II and III studies. However, most of the enrolled patients were treatment naive or had experienced a wash-out period before the introduction of mirabegron. No study has reported the treatment results of a direct switch from antimuscarinics to mirabegron, which may more commonly occur in clinical practice. This is an observational study to assess the therapeutic efficacy and safety of directly switching from antimuscarinics to mirabegron in patients with OAB receiving stable antimuscarinic treatment. Moreover, we sought to identify the patients who benefited more from the change. Patients aged ≥20 years with OAB receiving stable antimuscarinics for >3 months were enrolled. Antimuscarinics were discontinued in all patients and mirabegron 25 mg, once daily was initiated. Primary end-point was global response assessment (GRA) at 1 month after medication switching. Baseline parameters and parameters changed 1 month after medication switching were compared between patients with GRA ≥ 1 and GRA < 1. Of the 282 enrolled patients (209 men, 73 women; mean age, 74.4 years), 55.3% had better (GRA ≥ 1), 31.2% had similar (GRA = 0), and 10.3% had worse (GRA < 0) outcomes. The overall adverse events (AE) rate decreased from 24.1% to 12.8%. In overall patients, there was no significant improvement of OAB symptoms, but postvoid residual (PVR) urine decreased and voiding symptoms and quality of life index improved significantly. Patients with GRA ≥ 1 had significantly improved both storage and voiding symptoms. A total of 195 patients (69.1%) can maintain mirabegron without adding or resuming antimuscarinics for more than 3 months. Logistic regression analysis indicated that higher baseline OAB symptoms scores were predictor of satisfactory outcome. More than 50% patients exhibited better outcomes after switching from antimuscarinics to mirabegron. Significantly lower AE rates and decreased PVR were noted. Higher baseline OAB symptom scores may predict a better outcome." @default.
• W2554368131 created "2016-11-30" @default.
• W2554368131 creator A5029982064 @default.
• W2554368131 creator A5053694613 @default.
• W2554368131 date "2016-11-01" @default.
• W2554368131 modified "2023-10-02" @default.
• W2554368131 title "High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatment" @default.
• W2554368131 cites W1567182779 @default.
• W2554368131 cites W1787320721 @default.
• W2554368131 cites W1972477468 @default.
• W2554368131 cites W1973376209 @default.
• W2554368131 cites W1985502561 @default.
• W2554368131 cites W1986758727 @default.
• W2554368131 cites W1987967806 @default.
• W2554368131 cites W1994890238 @default.
• W2554368131 cites W1998032340 @default.
• W2554368131 cites W2007465833 @default.
• W2554368131 cites W2018377518 @default.
• W2554368131 cites W2030602028 @default.
• W2554368131 cites W2056255004 @default.
• W2554368131 cites W2063677232 @default.
• W2554368131 cites W2072862004 @default.
• W2554368131 cites W2093767304 @default.
• W2554368131 cites W2096198028 @default.
• W2554368131 cites W2116324813 @default.
• W2554368131 cites W2121960800 @default.
• W2554368131 cites W2133603145 @default.
• W2554368131 cites W2148884191 @default.
• W2554368131 cites W2169016904 @default.
• W2554368131 cites W2212452621 @default.
• W2554368131 cites W2216831827 @default.
• W2554368131 doi "https://doi.org/10.1097/md.0000000000004962" @default.
• W2554368131 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5106046" @default.
• W2554368131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27828840" @default.
• W2554368131 hasPublicationYear "2016" @default.
• W2554368131 type Work @default.
• W2554368131 sameAs 2554368131 @default.
• W2554368131 citedByCount "14" @default.
• W2554368131 countsByYear W25543681312017 @default.
• W2554368131 countsByYear W25543681312018 @default.
• W2554368131 countsByYear W25543681312019 @default.
• W2554368131 countsByYear W25543681312021 @default.
• W2554368131 countsByYear W25543681312022 @default.
• W2554368131 countsByYear W25543681312023 @default.
• W2554368131 crossrefType "journal-article" @default.
• W2554368131 hasAuthorship W2554368131A5029982064 @default.
• W2554368131 hasAuthorship W2554368131A5053694613 @default.
• W2554368131 hasBestOaLocation W25543681311 @default.
• W2554368131 hasConcept C126322002 @default.
• W2554368131 hasConcept C126894567 @default.
• W2554368131 hasConcept C142724271 @default.
• W2554368131 hasConcept C159110408 @default.
• W2554368131 hasConcept C197934379 @default.
• W2554368131 hasConcept C203092338 @default.
• W2554368131 hasConcept C204787440 @default.
• W2554368131 hasConcept C2778164427 @default.
• W2554368131 hasConcept C2778941218 @default.
• W2554368131 hasConcept C2779951463 @default.
• W2554368131 hasConcept C535046627 @default.
• W2554368131 hasConcept C71924100 @default.
• W2554368131 hasConceptScore W2554368131C126322002 @default.
• W2554368131 hasConceptScore W2554368131C126894567 @default.
• W2554368131 hasConceptScore W2554368131C142724271 @default.
• W2554368131 hasConceptScore W2554368131C159110408 @default.
• W2554368131 hasConceptScore W2554368131C197934379 @default.
• W2554368131 hasConceptScore W2554368131C203092338 @default.
• W2554368131 hasConceptScore W2554368131C204787440 @default.
• W2554368131 hasConceptScore W2554368131C2778164427 @default.
• W2554368131 hasConceptScore W2554368131C2778941218 @default.
• W2554368131 hasConceptScore W2554368131C2779951463 @default.
• W2554368131 hasConceptScore W2554368131C535046627 @default.
• W2554368131 hasConceptScore W2554368131C71924100 @default.
• W2554368131 hasIssue "45" @default.
• W2554368131 hasLocation W25543681311 @default.
• W2554368131 hasLocation W25543681312 @default.
• W2554368131 hasLocation W25543681313 @default.
• W2554368131 hasOpenAccess W2554368131 @default.
• W2554368131 hasPrimaryLocation W25543681311 @default.
• W2554368131 hasRelatedWork W1981353722 @default.
• W2554368131 hasRelatedWork W2003638941 @default.
• W2554368131 hasRelatedWork W2082431080 @default.
• W2554368131 hasRelatedWork W2313053739 @default.
• W2554368131 hasRelatedWork W2540498085 @default.
• W2554368131 hasRelatedWork W2743658275 @default.
• W2554368131 hasRelatedWork W2784905695 @default.
• W2554368131 hasRelatedWork W2920863390 @default.
• W2554368131 hasRelatedWork W2984558133 @default.
• W2554368131 hasRelatedWork W3171971260 @default.
• W2554368131 hasVolume "95" @default.
• W2554368131 isParatext "false" @default.
• W2554368131 isRetracted "false" @default.
• W2554368131 magId "2554368131" @default.
• W2554368131 workType "article" @default.